TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

CUSIP: 88338N206

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
+1,982,707
Put/Call ratio
188%
SEC-reported price per share
$9.95
Number of holders
36
Value change
+$19,831,622
Number of buys
36
Open additional details 1 more signal available
Number of sells
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
11,676,558

Security key

88338N206

Report period

Q2 2022

Institutions

36

Top holders

10

Ownership snapshot

Top reported holders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
John C.k. Milligan IV
Disclosed value leader
John C.k. Milligan IV
Comparable rows
0/15
Latest evidence
31 Mar 2022
3/4/5 13F Highest disclosed value: $12,698,322 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

John C.k. Milligan IV has the largest disclosed position value at $12.7M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens John C.k. Milligan IV's linked filing trail.
Disclosed position value Top 5
John C.k. Milligan IV $12.7M
Hugh O'Dowd $11.42M
BlackRock Finance, Inc. $9.29M
VANGUARD GROUP INC $6.63M
Robert G. Finizio $5.31M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
John C.k. Milligan IV
3/4/5
Secretary/CEO of subsidiary
mixed-class rows
$12,698,322
5,542,076 shares
mixed-class rows
10 May 2021
Hugh O'Dowd
3/4/5
Chief Executive Officer
mixed-class rows
$11,415,713
4,250,000 shares
mixed-class rows
31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
class O/S missing
$9,286,000
24,442,512 shares
31 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
class O/S missing
$6,631,000
17,448,224 shares
31 Mar 2022
Robert G. Finizio
3/4/5
CEO, Director
mixed-class rows
$5,305,888
2,240,000 shares
mixed-class rows
01 Jul 2021
STATE STREET CORP
13F
Company
13F
class O/S missing
$2,758,000
7,259,095 shares
31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
36
Shares
1,993,507
Rows available
36
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
2
Q2 2022 holders
36
Holder diff
34
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .